# Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy

> **NCT03555851** · — · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 120 (estimated)

## Conditions studied

- Leukemia, Not Otherwise Specified
- Leukemia, Other

## Interventions

- **DRUG:** Cyclophosphamide
- **OTHER:** Specimen collection

## Key facts

- **NCT ID:** NCT03555851
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-13
- **Primary completion:** 2033-10
- **Final completion:** 2035-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03555851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03555851, "Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03555851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*